Skip to main content
Year archive

J.B. Chemicals & Pharmaceuticals Lt — 2025 filings

All 257 regulatory filings released by J.B. Chemicals & Pharmaceuticals Lt (JBCHEPHARM) in 2025, sourced directly from the official regulator.

257 Filings
2025 Period
2025 filings (257)
Filing Released Lang
Receipt of Order
Regulatory Filings
2025-12-30 English
Action(s) initiated or orders passed
Regulatory Filings
2025-12-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-12-29 English
Board Meeting — Financial Results
Regulatory Filings
2025-12-29 English
Trading Window
Regulatory Filings
2025-12-29 English
JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2026 ,inter alia, to consider and approve the unaudited ....
Regulatory Filings
2025-12-29 English
Intimation of Trading Window closure period
Regulatory Filings
2025-12-29 English
General Updates
Regulatory Filings
2025-12-24 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order
Regulatory Filings
2025-12-24 English
General Updates
Environmental & Social Information
2025-12-22 English
DJSI (Dow Jones Sustainable Index) ESG Score Release
Environmental & Social Information
2025-12-22 English
General Updates
Regulatory Filings
2025-12-16 English
Receipt of order from the Joint Commissioner of State Tax, Uttar Pradesh
Regulatory Filings
2025-12-16 English
Post Offer Public Announcement
Regulatory Filings
2025-12-09 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post Offer Advertisement under Regulations 18(12) of the SEBI (Substantial Acquisition of Shares and ....
M&A Activity
2025-12-09 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-12-06 English
Allotment of Equity Shares on exercise of stock options pursuant to ESOP Scheme
Share Issue/Capital Change
2025-12-06 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-11-23 English
Allotment of Equity Shares on exercise of stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-11-23 English
Updates
M&A Activity
2025-11-17 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Advertisement under Regulations 18(7) of Securities and Exchange Board of India (Substantial ....
M&A Activity
2025-11-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-11-14 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-11-14 English
Transcript of Investors/Analysts call
Call Transcript
2025-11-14 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-11-14 English
Updates
Regulatory Filings
2025-11-12 English
Newspaper Advertisement pertaining to Recommendations of the Committee of Independent Directors on the Open Offer
Regulatory Filings
2025-11-12 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-11-12 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2025-11-12 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-12 English
Newspaper advertisement pertaining to financial results for the quarter and half year ended September 30, 2025
Regulatory Filings
2025-11-12 English
Press Release
Earnings Release
2025-11-11 English
Investor Presentation
Investor Presentation
2025-11-11 English
Investor Presentation
Investor Presentation
2025-11-11 English
Outcome of Board Meeting
Regulatory Filings
2025-11-11 English
Press Release
Earnings Release
2025-11-11 English
Outcome of meeting of Board of Directors.
Regulatory Filings
2025-11-11 English
Updates
Merger & Acquisition
2025-11-07 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the eligible shareholders of JB Chemicals & Pharmaceuticals Ltd ....
M&A Activity
2025-11-07 English
Newspaper Publication regarding shifting of registered office of the Company from Maharashtra to Gujarat
Regulatory Filings
2025-10-31 English
Copy of Newspaper Publication
Regulatory Filings
2025-10-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-10-31 English
Update on Investors/analysts call with management
Call Transcript
2025-10-31 English
Newspaper Publication regarding change in Registered Office
Call Transcript
2025-10-31 English
4th Sustainability (ESG) Report
Regulatory Filings
2025-10-24 English
Updates
Regulatory Filings
2025-10-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-10-24 English
Investors/analysts call with management
Call Transcript
2025-10-24 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-24 English
JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the unaudited ....
Regulatory Filings
2025-10-24 English
Board Meeting — Financial Results
Regulatory Filings
2025-10-24 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-10-08 English
Certificate under Reg.74 (5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2025-10-08 English
Trading Window
Regulatory Filings
2025-09-30 English
Intimation of Trading Window closure period
Regulatory Filings
2025-09-30 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order
Regulatory Filings
2025-09-08 English
General Updates
Regulatory Filings
2025-09-08 English
Corrigendum
Regulatory Filings
2025-09-04 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Corrigendum to the Public Announcement, Detailed Public Statement and the Draft Letter of Offer for ....
Regulatory Filings
2025-09-04 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-09-01 English
Allotment of equity shares on exercise of stock options pursuant to employee stock option scheme
Share Issue/Capital Change
2025-09-01 English
Cessation of Non-Executive Independent Director upon completion of term
Board/Management Information
2025-08-31 English
Cessation
Board/Management Information
2025-08-31 English
Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-08-14 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-08-14 English
Allotment of Equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-08-11 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-08-11 English
Result of Voting at Annual General Meeting alongwith Scrutinizer''s Report on Voting
Regulatory Filings
2025-08-06 English
Shareholders meeting
Regulatory Filings
2025-08-06 English
Change in Auditors
Regulatory Filings
2025-08-06 English
General Updates
Regulatory Filings
2025-08-06 English
Change in Auditors
Board/Management Information
2025-08-06 English
Appointment
Board/Management Information
2025-08-06 English
Appointment
Board/Management Information
2025-08-06 English
Appointment
Board/Management Information
2025-08-06 English
Appointment
Board/Management Information
2025-08-06 English
Shareholders meeting
AGM Information
2025-08-06 English
Change in Registered office of the Company
Regulatory Filings
2025-08-06 English
Appointment of Secretarial Auditors
Regulatory Filings
2025-08-06 English
Re-appointment of Statutory Auditors
Board/Management Information
2025-08-06 English
Re-appointment of Mr. Nikhil Chopra as CEO and Whole-time Director
Board/Management Information
2025-08-06 English
Re-appointment of Mr. Sumit Bose as Non-Executive Independent Director of the Company
Board/Management Information
2025-08-06 English
Appointment of Ms. Richa Arora as Non-Executive Independent Director of the Company
Board/Management Information
2025-08-06 English
Appointment of Mr. Ashwani Kumar Puri as Non-Executive Independent Director of the Company
Board/Management Information
2025-08-06 English
Proceedings of the Annual General Meeting
AGM Information
2025-08-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-08-05 English
Transcript of Investor / Analyst call
Call Transcript
2025-08-05 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2025-07-31 English
Newspaper advertisement pertaining to financial results for quarter ended June 30, 2025
Earnings Release
2025-07-31 English
Copy of Newspaper Publication
Regulatory Filings
2025-07-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-07-31 English
Press Release
Earnings Release
2025-07-30 English
Investor Presentation
Investor Presentation
2025-07-30 English
Investor Presentation
Investor Presentation
2025-07-30 English
Outcome of Board Meeting
Regulatory Filings
2025-07-30 English
Press Release
Earnings Release
2025-07-30 English
Unaudited standalone and consolidated financial results for the quarter ended on June 30, 2025 accompanied by limited review report.
Regulatory Filings
2025-07-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-07-23 English
Investors/analysts call with Management
Regulatory Filings
2025-07-23 English
Allotment of Securities
Share Issue/Capital Change
2025-07-22 English
Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-07-22 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-21 English
Board Meeting — Financial Results
Regulatory Filings
2025-07-21 English
JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve the unaudited ....
Regulatory Filings
2025-07-21 English
Letter to shareholders - Integrated Annual Report 2024-25
Report Publication Announcement
2025-07-17 English
Updates
Report Publication Announcement
2025-07-17 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-07-17 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-07-17 English
Copy of Newspaper Publication
Regulatory Filings
2025-07-12 English
Newspaper advertisement
Regulatory Filings
2025-07-12 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company").
Regulatory Filings
2025-07-12 English
BRSR
Environmental & Social Information
2025-07-11 English
Intimation of Record date
Notice of Dividend Amount
2025-07-11 English
Record Date
Notice of Dividend Amount
2025-07-11 English
Shareholders meeting
AGM Information
2025-07-11 English
Annual Report For the Financial Year 2024-25
Annual Report
2025-07-11 English
Notice of Annual General Meeting to be held on August 6, 2025 at 1:30 pm.
AGM Information
2025-07-11 English
Appointment
Board/Management Information
2025-07-10 English
Change in Director - Appointment of Non-Executive Independent Director
Board/Management Information
2025-07-10 English
Copy of Newspaper Publication
Regulatory Filings
2025-07-04 English
Newspaper Publication of Detailed Public Statement in connection with the open offer
Regulatory Filings
2025-07-04 English
Public Announcement-Open Offer
Regulatory Filings
2025-07-04 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4), 14 (3) and ....
Regulatory Filings
2025-07-04 English
Public Announcement-Open Offer
Regulatory Filings
2025-06-30 English
Investor Presentation
Regulatory Filings
2025-06-30 English
Investor Presentation
Regulatory Filings
2025-06-30 English
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13(1), 14 and 15(1) of the Securities ....
Regulatory Filings
2025-06-30 English
Public Announcement-Open Offer
Regulatory Filings
2025-06-30 English
General Updates
M&A Activity
2025-06-29 English
Public Announcement of open offer for acquisition of Company''s equity shares
M&A Activity
2025-06-29 English
Amalgamation/Merger
M&A Activity
2025-06-29 English
Disclosure under Regulation 30 - Outcome of the Board meeting
Capital/Financing Update
2025-06-29 English
General Updates
Regulatory Filings
2025-06-29 English
Change in registered office of the Company
Regulatory Filings
2025-06-29 English
Press Release
M&A Activity
2025-06-29 English
Press Release
M&A Activity
2025-06-29 English
Appointment
Board/Management Information
2025-06-28 English
Re-appointment of Mr. Nikhil Chopra, Chief Executive Officer- Whole time- Director
Board/Management Information
2025-06-28 English
Intimation of Trading Window Closure period
Regulatory Filings
2025-06-27 English
Trading Window
Regulatory Filings
2025-06-27 English
Disclosure made to the stock exchange on June 24, 2025 and exchange email dated June 26, 2025
Regulatory Filings
2025-06-26 English
Updates
Regulatory Filings
2025-06-24 English
ANDA Approval by US FDA
Regulatory Filings
2025-06-24 English
Copy of Newspaper Publication
AGM Information
2025-06-18 English
Newspaper advertisement - transfer of shares to IEPF
AGM Information
2025-06-18 English
Copy of Newspaper Publication
AGM Information
2025-06-17 English
Prior public notice for equity shareholders of the Company with regard to convening the AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM)
AGM Information
2025-06-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-06-16 English
Intimation of schedule of Analysts/Institutional investors meet
Regulatory Filings
2025-06-16 English
Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-06-11 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-06-11 English
Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-06-05 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-06-05 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-05-25 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-05-25 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-05-20 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-05-20 English
Transcript of Investors/Analysts call
Call Transcript
2025-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-15 English
Copy of Newspaper Publication
Regulatory Filings
2025-05-15 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2025-05-15 English
Newspaper advertisement pertaining to financial results for quarter and year ended on March 31, 2025
Report Publication Announcement
2025-05-15 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2025-05-14 English
Annual Secretarial Compliance
Regulatory Filings
2025-05-14 English
General Updates
Board/Management Information
2025-05-14 English
General Updates
Regulatory Filings
2025-05-14 English
Appointment
Board/Management Information
2025-05-14 English
Appointment
Board/Management Information
2025-05-14 English
Appointment of Secretarial Auditor
Board/Management Information
2025-05-14 English
Re-appointment of Non-Executive Independent Director
Board/Management Information
2025-05-14 English
Appointment of Non-Executive Independent Director
Board/Management Information
2025-05-14 English
Re-appointment of Statutory Auditors
Regulatory Filings
2025-05-14 English
Dividend
Notice of Dividend Amount
2025-05-14 English
Recommendation of Final Dividend of Rs. 7 (700%) per equity share of FV of Re. 1 each for FY 2024-25
Notice of Dividend Amount
2025-05-14 English
Investor Presentation
Investor Presentation
2025-05-14 English
Press Release
Earnings Release
2025-05-14 English
Audited Standalone and Consolidated Financial Results for the year ended on March 31, 2025
Regulatory Filings
2025-05-14 English
Outcome of Board Meeting
Regulatory Filings
2025-05-14 English
Presentation
Investor Presentation
2025-05-14 English
Press Release
Earnings Release
2025-05-14 English
Audited standalone and Consolidated financial results for the year ended on March 31, 2025 accompanied by Auditors' Report.
Regulatory Filings
2025-05-14 English
Intimation of schedule of Analysts/Institutional investors meet
Investor Presentation
2025-05-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-14 English
Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-05-06 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-05-06 English
Investors/analysts call with management
Call Transcript
2025-04-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-04-23 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-04-22 English
JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve (i) the audited ....
Regulatory Filings
2025-04-22 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-04-22 English
Updates
Regulatory Filings
2025-04-18 English
ANDA Approval by US FDA
Regulatory Filings
2025-04-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-04-14 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-04-14 English
Disclosure submitted to exchange on April 2, 2025 and exchange email dated April 11, 2025
Capital/Financing Update
2025-04-11 English
Disclosure submitted to the exchange on April 2, 2025 and exchange email dated April 11, 2025
Regulatory Filings
2025-04-11 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2025-04-04 English
Updates
Regulatory Filings
2025-04-02 English
General Updates
Capital/Financing Update
2025-04-02 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for abrdn Asia Ltd
Major Shareholding Notification
2025-04-01 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Cautionary Letter
Regulatory Filings
2025-03-29 English
General Updates
Regulatory Filings
2025-03-29 English
Trading Window
Regulatory Filings
2025-03-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investment Holdings Pte Ltd & PACs
Major Shareholding Notification
2025-03-28 English
Allotment of Equity shares on exercise of stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-03-18 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-03-18 English
USFDA inspection of Company''s API manufacturing facility - D9 at Panoli, Gujarat
Regulatory Filings
2025-03-14 English
Updates
Regulatory Filings
2025-03-14 English
USFDA inspection of Company''s manufacturing facility - T20 at Panoli, Gujarat
Regulatory Filings
2025-03-08 English
Updates
Regulatory Filings
2025-03-08 English
DJSI (Dow Jones Sustainable Index) ESG Score release
Environmental & Social Information
2025-03-05 English
Updates
Environmental & Social Information
2025-03-05 English
General Updates
Legal Proceedings Report
2025-02-28 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order
Regulatory Filings
2025-02-28 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-02-27 English
Allotment of equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-02-27 English
Intimation of schedule of Analysts/ Institutional Investors meet
Regulatory Filings
2025-02-19 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order
Regulatory Filings
2025-02-19 English
General Updates
Regulatory Filings
2025-02-19 English
General Updates
Regulatory Filings
2025-02-19 English
Transcript of Investors/Analysts call
Call Transcript
2025-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-02-10 English
Audio recording of Investors/analysts call with Management
Call Transcript
2025-02-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-02-05 English
Newspaper cutting of extract of consolidated financial results for the quarter ended on December 31, 2024
Earnings Release
2025-02-05 English
Copy of Newspaper Publication
Regulatory Filings
2025-02-05 English
Integrated filing (Financial) for the quarter and nine months ended December 31, 2024
Regulatory Filings
2025-02-04 English
Integrated Filing- Financial
Regulatory Filings
2025-02-04 English
Updates
Regulatory Filings
2025-02-04 English
Board comments on fine levied by the Exchange for delayed compliance
Regulatory Filings
2025-02-04 English
Record Date
Notice of Dividend Amount
2025-02-04 English
Dividend
Notice of Dividend Amount
2025-02-04 English
Intimation of record date
Notice of Dividend Amount
2025-02-04 English
Declaration of interim dividend of Rs. 8.5 per equity share of Fv Re. 1 each for the FY 2024-25
Notice of Dividend Amount
2025-02-04 English
Investor Presentation
Investor Presentation
2025-02-04 English
Press Release
Earnings Release
2025-02-04 English
Financial Result Updates
Regulatory Filings
2025-02-04 English
Investor Presentation
Investor Presentation
2025-02-04 English
Press Release
Earnings Release
2025-02-04 English
Unaudited Financial Results for the quarter ended on December 31, 2024
Regulatory Filings
2025-02-04 English
General Updates
Regulatory Filings
2025-02-04 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order
Regulatory Filings
2025-02-04 English
Investors/Analysts call with Management
Call Transcript
2025-01-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-01-24 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-24 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-01-24 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve (i) unaudited ....
Regulatory Filings
2025-01-24 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-01-24 English
Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2025-01-24 English
Updates
Regulatory Filings
2025-01-16 English
Updates
Investor Presentation
2025-01-16 English
Presentation
Investor Presentation
2025-01-16 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order
Regulatory Filings
2025-01-16 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-01-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-01-07 English